Oncolytics Biotech, Inc. (ONCY) stock prices updated...

Oncolytics Biotech, Inc. stock price

Oncolytics Biotech, Inc. latest news:

  • 11/16/2017 15:12:31

    BRIEF-Oncolytics Biotech and Adlai Nortye enter into $86.6 mln regional licensing agreement for Reolysin

    Oncolytics Biotech Inc(ONCYF). * Oncolytics Biotech® Inc. and Adlai Nortye enter into $86.6 million regional licensing agreement for Reolysin®. * Oncolytics Biotech Inc (ONCYF) - ‍Oncolytics to receive upfront, licensing fee and milestone payments to support phase 3 registration study of usd $21.2 million​. * Oncolytics Biotech (ONCYF) - ‍Co is eligible to receive up to additional $65.4 million upon achieveme...

  • More trends:

    OncoMed Pharmaceuticals, Inc.OMED | Onconova Therapeutics, Inc.ONTX | OncoSec Medical IncorporatedONCS | Oncothyreon Inc.ONTY | One Horizon Group, Inc.OHGI | Oneida Financial Corp.ONFC | Onvia, Inc.ONVI | Open Text CorporationOTEX | Opexa Therapeutics, Inc.OPXA | Opexa Therapeutics, Inc.OPXAW |